{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:52:10Z","timestamp":1765381930505,"version":"3.40.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00253-015-6787-7","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T02:56:32Z","timestamp":1436151392000},"page":"7625-7637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prediction of T cell epitopes of Brucella abortus and evaluation of their protective role in mice"],"prefix":"10.1007","volume":"99","author":[{"given":"Prachiti","family":"Afley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir K.","family":"Dohre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. B. K. S.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"issue":"8","key":"6787_CR1","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","volume":"69","author":"A Al-Mariri","year":"2001","unstructured":"Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ (2001) Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun 69(8):4816\u20134822","journal-title":"Infect Immun"},{"issue":"2","key":"6787_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1128\/IAI.01017-08","volume":"77","author":"AM Arenas-Gamboa","year":"2009","unstructured":"Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Gomez G, Rice-Ficht AC (2009) The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle. Infect Immun 77(2):877\u2013884","journal-title":"Infect Immun"},{"issue":"4","key":"6787_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4065\/77.4.339","volume":"77","author":"C Buteau","year":"2002","unstructured":"Buteau C, Markovic SN, Celis E (2002) Challenges in the development of effective peptide vaccines for cancer. Mayo Clin Proc 77(4):339\u2013349","journal-title":"Mayo Clin Proc"},{"issue":"19-20","key":"6787_CR4","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/S0264-410X(02)00159-7","volume":"20","author":"A Cloeckaert","year":"2002","unstructured":"Cloeckaert A, Grayon M, Grepinet O (2002) Identification of Brucella melitensis vaccine strain Rev.1 by PCR-RFLP based on a mutation in the rpsL gene. Vaccine 20(19-20):2546\u20132550","journal-title":"Vaccine"},{"issue":"1","key":"6787_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","volume":"25","author":"NJ Commander","year":"2007","unstructured":"Commander NJ, Spencer SA, Wren BW, MacMillan AP (2007) The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes. Vaccine 25(1):43\u201354","journal-title":"Vaccine"},{"issue":"13","key":"6787_CR6","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1002\/pmic.200500730","volume":"6","author":"JP Connolly","year":"2006","unstructured":"Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Grewal P, Mujer CV, Ugalde RA, DelVecchio VG (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6(13):3767\u20133780","journal-title":"Proteomics"},{"issue":"2","key":"6787_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3201\/eid0302.970219","volume":"3","author":"MJ Corbel","year":"1997","unstructured":"Corbel MJ (1997) Brucellosis: an overview. Emerg Infect Dis 3(2):213\u2013221","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"6787_CR8","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.4161\/hv.25611","volume":"9","author":"AS De Groot","year":"2013","unstructured":"De Groot AS, Einck L, Moise L, Chambers M, Ballantyne J, Malone RW, Ardito M, Martin W (2013) Making vaccines \u201con demand\u201d: a potential solution for emerging pathogens and biodefense? Hum Vaccin Immunother 9(9):1877\u20131884","journal-title":"Hum Vaccin Immunother"},{"issue":"37-38","key":"6787_CR9","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","volume":"25","author":"MV Delpino","year":"2007","unstructured":"Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J (2007) Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice. Vaccine 25(37-38):6721\u20136729","journal-title":"Vaccine"},{"issue":"1","key":"6787_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/IAI.00994-09","volume":"78","author":"MA Durward","year":"2010","unstructured":"Durward MA, Harms J, Magnani DM, Eskra L, Splitter GA (2010) Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo. Infect Immun 78(1):168\u2013176","journal-title":"Infect Immun"},{"issue":"3","key":"6787_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0378-1135(02)00110-4","volume":"88","author":"MD Edmonds","year":"2002","unstructured":"Edmonds MD, Cloeckaert A, Elzer PH (2002) Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis. Vet Microbiol 88(3):205\u2013221","journal-title":"Vet Microbiol"},{"issue":"9","key":"6787_CR12","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/iai.59.9.2978-2986.1991","volume":"59","author":"JH Eldridge","year":"1991","unstructured":"Eldridge JH, Staas JK, Meulbroek JA, Tice TR, Gilley RM (1991) Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun 59(9):2978\u20132986","journal-title":"Infect Immun"},{"issue":"48","key":"6787_CR13","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1016\/j.vaccine.2009.08.097","volume":"27","author":"SM Estein","year":"2009","unstructured":"Estein SM, Fiorentino MA, Paolicchi FA, Clausse M, Manazza J, Cassataro J, Giambartolomei GH, Coria LM, Zylberman V, Fossati CA, Kjeken R, Goldbaum FA (2009) The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams. Vaccine 27(48):6704\u20136711","journal-title":"Vaccine"},{"issue":"12","key":"6787_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","volume":"7","author":"MP Franco","year":"2007","unstructured":"Franco MP, Mulder M, Gilman RH, Smits HL (2007) Human brucellosis. Lancet Infect Dis 7(12):775\u2013786","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"6787_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0092-8674(94)90336-0","volume":"76","author":"RN Germain","year":"1994","unstructured":"Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76(2):287\u2013299","journal-title":"Cell"},{"issue":"8","key":"6787_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/infdis\/jiq171","volume":"203","author":"R Goenka","year":"2011","unstructured":"Goenka R, Parent MA, Elzer PH, Baldwin CL (2011) B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus. J Infect Dis 203(8):1136\u20131146","journal-title":"J Infect Dis"},{"issue":"9","key":"6787_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1099\/00222615-48-9-833","volume":"48","author":"FA Goldbaum","year":"1999","unstructured":"Goldbaum FA, Velikovsky CA, Baldi PC, Mortl S, Bacher A, Fossati CA (1999) The 18-kDa cytoplasmic protein of Brucella species\u2014an antigen useful for diagnosis\u2014is a lumazine synthase. J Med Microbiol 48(9):833\u2013839","journal-title":"J Med Microbiol"},{"issue":"3","key":"6787_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.rvsc.2006.07.014","volume":"82","author":"VK Gupta","year":"2007","unstructured":"Gupta VK, Rout PK, Vihan VS (2007) Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M. Res Vet Sci 82(3):305\u2013313","journal-title":"Res Vet Sci"},{"issue":"6","key":"6787_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/clinids\/12.6.1060","volume":"12","author":"WH Hall","year":"1990","unstructured":"Hall WH (1990) Modern chemotherapy for brucellosis in humans. Rev Infect Dis 12(6):1060\u20131099","journal-title":"Rev Infect Dis"},{"issue":"9","key":"6787_CR20","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1128\/IAI.69.9.5502-5508.2001","volume":"69","author":"Y He","year":"2001","unstructured":"He Y, Vemulapalli R, Zeytun A, Schurig GG (2001) Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun 69(9):5502\u20135508","journal-title":"Infect Immun"},{"issue":"11","key":"6787_CR21","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1128\/IAI.67.11.5877-5884.1999","volume":"67","author":"DL Hoover","year":"1999","unstructured":"Hoover DL, Crawford RM, Van De Verg LL, Izadjoo MJ, Bhattacharjee AK, Paranavitana CM, Warren RL, Nikolich MP, Hadfield TL (1999) Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK). Infect Immun 67(11):5877\u20135884","journal-title":"Infect Immun"},{"issue":"5","key":"6787_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s11274-012-1247-3","volume":"29","author":"S Jain","year":"2013","unstructured":"Jain S, Afley P, Kumar S (2013) Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB\/c mice. World J Microbiol Biotechnol 29(5):907\u2013913","journal-title":"World J Microbiol Biotechnol"},{"issue":"35","key":"6787_CR23","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1016\/j.vaccine.2014.06.012","volume":"32","author":"S Jain","year":"2014","unstructured":"Jain S, Afley P, Dohre SK, Saxena N, Kumar S (2014a) Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB\/c mice. Vaccine 32(35):4537\u20134542","journal-title":"Vaccine"},{"issue":"1","key":"6787_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/2049-632X.12079","volume":"70","author":"S Jain","year":"2014","unstructured":"Jain S, Kumar S, Dohre S, Afley P, Sengupta N, Alam SI (2014b) Identification of a protective protein from stationary-phase exoproteome of Brucella abortus. Pathog Dis 70(1):75\u201383","journal-title":"Pathog Dis"},{"issue":"1","key":"6787_CR25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/iai.61.1.124-134.1993","volume":"61","author":"X Jiang","year":"1993","unstructured":"Jiang X, Baldwin CL (1993) Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun 61(1):124\u2013134","journal-title":"Infect Immun"},{"issue":"2","key":"6787_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0165-2478(91)90030-E","volume":"30","author":"WM Kast","year":"1991","unstructured":"Kast WM, Melief CJ (1991) In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes. Immunol Lett 30(2):229\u2013232","journal-title":"Immunol Lett"},{"issue":"1","key":"6787_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10482-008-9292-5","volume":"95","author":"S Kumar","year":"2009","unstructured":"Kumar S, Balakrishna K, Agarwal GS, Merwyn S, Rai GP, Batra HV, Sardesai AA, Gowrishankar J (2009) Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model. Antonie Van Leeuwenhoek 95(1):91\u2013100","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"Suppl 2","key":"6787_CR28","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1073\/pnas.0404845101","volume":"101","author":"M Liu","year":"2004","unstructured":"Liu M, Acres B, Balloul JM, Bizouarne N, Paul S, Slos P, Squiban P (2004) Gene-based vaccines and immunotherapeutics. Proc Natl Acad Sci U S A 101(Suppl 2):14567\u201314571","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"6787_CR29","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","volume":"74","author":"D Luo","year":"2006","unstructured":"Luo D, Ni B, Li P, Shi W, Zhang S, Han Y, Mao L, He Y, Wu Y, Wang X (2006) Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice. Infect Immun 74(5):2734\u20132741","journal-title":"Infect Immun"},{"issue":"2-3","key":"6787_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000050034","volume":"44","author":"JS Moynihan","year":"2001","unstructured":"Moynihan JS, Howard CR (2001) Recent advances in the development of peptide vaccines for hepatitis B. Intervirology 44(2-3):65\u201377","journal-title":"Intervirology"},{"issue":"4","key":"6787_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","volume":"103","author":"EA Murphy","year":"2001","unstructured":"Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL (2001) Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice. Immunology 103(4):511\u2013518","journal-title":"Immunology"},{"key":"6787_CR32","first-page":"147","volume":"13","author":"P Nicoletti","year":"1990","unstructured":"Nicoletti P (1990) Vaccination against Brucella. Adv Biotechnol Process 13:147\u2013168","journal-title":"Adv Biotechnol Process"},{"issue":"5","key":"6787_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.vaccine.2004.06.037","volume":"23","author":"DT O\u2019Hagan","year":"2004","unstructured":"O\u2019Hagan DT, Singh M, Dong C, Ugozzoli M, Berger K, Glazer E, Selby M, Wininger M, Ng P, Crawford K, Paliard X, Coates S, Houghton M (2004) Cationic microparticles are a potent delivery system for a HCV DNA vaccine. Vaccine 23(5):672\u2013680","journal-title":"Vaccine"},{"issue":"1","key":"6787_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/S0100-879X1998000100010","volume":"31","author":"SCHJ Oliveira","year":"1998","unstructured":"Oliveira SCHJ, Rech EL, Rodarte RS, Bocca AL, Goes AM, Splitter GA (1998) The role of T cell subsets and cytokines in the regulation of intracellularbacterial infection. Braz J Med Biol Res 31(1):77\u201384","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"6787_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cyto.2004.12.009","volume":"30","author":"C Paranavitana","year":"2005","unstructured":"Paranavitana C, Zelazowska E, Izadjoo M, Hoover D (2005) Interferon-gamma associated cytokines and chemokines produced by spleen cells from Brucella-immune mice. Cytokine 30(2):86\u201392","journal-title":"Cytokine"},{"issue":"1","key":"6787_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1128\/IAI.01151-08","volume":"77","author":"KA Pasquevich","year":"2009","unstructured":"Pasquevich KA, Estein SM, Garcia Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J (2009) Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 77(1):436\u2013445","journal-title":"Infect Immun"},{"issue":"3","key":"6787_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","volume":"34","author":"SD Perkins","year":"2010","unstructured":"Perkins SD, Smither SJ, Atkins HS (2010) Towards a Brucella vaccine for humans. FEMS Microbiol Rev 34(3):379\u2013394","journal-title":"FEMS Microbiol Rev"},{"issue":"8","key":"6787_CR38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1099\/0022-1317-51-8-661","volume":"51","author":"GM Rosinha","year":"2002","unstructured":"Rosinha GM, Myioshi A, Azevedo V, Splitter GA, Oliveira SC (2002) Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation. J Med Microbiol 51(8):661\u2013671","journal-title":"J Med Microbiol"},{"issue":"6144","key":"6787_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/330106b0","volume":"330","author":"J Rothbard","year":"1987","unstructured":"Rothbard J (1987) Synthetic peptides as vaccines. Nature 330(6144):106\u2013107","journal-title":"Nature"},{"issue":"2","key":"6787_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","volume":"28","author":"GG Schurig","year":"1991","unstructured":"Schurig GG, Roop RM 2nd, Bagchi T, Boyle S, Buhrman D, Sriranganathan N (1991) Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 28(2):171\u2013188","journal-title":"Vet Microbiol"},{"issue":"12","key":"6787_CR41","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1007\/s11095-004-7666-6","volume":"21","author":"M Singh","year":"2004","unstructured":"Singh M, Chesko J, Kazzaz J, Ugozzoli M, Kan E, Srivastava I, O\u2019Hagan DT (2004) Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not. Pharm Res 21(12):2148\u20132152","journal-title":"Pharm Res"},{"issue":"6","key":"6787_CR42","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1128\/IAI.68.6.3286-3289.2000","volume":"68","author":"R Vemulapalli","year":"2000","unstructured":"Vemulapalli R, He Y, Cravero S, Sriranganathan N, Boyle SM, Schurig GG (2000) Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun 68(6):3286\u20133289","journal-title":"Infect Immun"},{"issue":"7","key":"6787_CR43","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1007\/s11274-012-1056-8","volume":"28","author":"SK Verma","year":"2012","unstructured":"Verma SK, Jain S, Kumar S (2012) Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB\/c mice. World J Microbiol Biotechnol 28(7):2487\u20132495","journal-title":"World J Microbiol Biotechnol"},{"issue":"12","key":"6787_CR44","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1128\/IAI.00761-12","volume":"80","author":"MA Vitry","year":"2012","unstructured":"Vitry MA, De Trez C, Goriely S, Dumoutier L, Akira S, Ryffel B, Carlier Y, Letesson JJ, Muraille E (2012) Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun 80(12):4271\u20134280","journal-title":"Infect Immun"},{"issue":"12","key":"6787_CR45","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1086\/588482","volume":"46","author":"G Vrioni","year":"2008","unstructured":"Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S (2008) An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 46(12):e131\u2013e136","journal-title":"Clin Infect Dis"},{"issue":"7","key":"6787_CR46","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1128\/IAI.01957-05","volume":"74","author":"X Yang","year":"2006","unstructured":"Yang X, Becker T, Walters N, Pascual DW (2006) Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun 74(7):3874\u20133879","journal-title":"Infect Immun"},{"issue":"12","key":"6787_CR47","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.vaccine.2006.12.004","volume":"25","author":"X Yang","year":"2007","unstructured":"Yang X, Walters N, Robison A, Trunkle T, Pascual DW (2007) Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization. Vaccine 25(12):2261\u20132268","journal-title":"Vaccine"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6787-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-015-6787-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6787-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6787-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:36:27Z","timestamp":1744173387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-015-6787-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":47,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["6787"],"URL":"https:\/\/doi.org\/10.1007\/s00253-015-6787-7","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"type":"print","value":"0175-7598"},{"type":"electronic","value":"1432-0614"}],"subject":[],"published":{"date-parts":[[2015,7,7]]},"assertion":[{"value":"2 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}